Carboplatin, Ipilimumab, Nivolumab, and Paclitaxel
About
Membership operator: AND
Therapies: 4
Therapies
Carboplatin (tx:ncit:C1282)
Ipilimumab (tx:ncit:C2654)
Nivolumab (tx:ncit:C68814)
Paclitaxel (tx:ncit:C1411)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (2) FDA (4) | Wild type ALK, Wild type EGFR | Non-Small Cell Lung Cancer | Carboplatin, Ipilimumab, Nivolumab, Paclitaxel |